| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,587 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,594 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,070 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,374 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,032 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
607 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7605123 |
Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof |
Oct. 20, 2009 |
| 7605122 |
Human chorionic gonadotropin (hCG) formulations for facilitating weight loss and body contouring |
Oct. 20, 2009 |
| 7605121 |
Oligopeptide lyophilisate, their preparation and use |
Oct. 20, 2009 |
| 7605120 |
Antagonists of the brandykinin B1 receptor |
Oct. 20, 2009 |
| 7605119 |
Memory enhancing protein method |
Oct. 20, 2009 |
| 7604950 |
Methods for early detection of pregnancy in cows |
Oct. 20, 2009 |
| 7604931 |
Cripto mutant and uses thereof |
Oct. 20, 2009 |
| 7601705 |
Polymer controlled induced viscosity fiber system and uses thereof |
Oct. 13, 2009 |
| 7601690 |
Cross-linked glycopeptide-cephalosporin antibiotics |
Oct. 13, 2009 |
| 7601687 |
Mechanism for identifying drugs for the treatment of type II diabetes |
Oct. 13, 2009 |
| 7601686 |
Hepatitis C virus inhibitors |
Oct. 13, 2009 |
| 7601685 |
Growth factor modified protein matrices for tissue engineering |
Oct. 13, 2009 |
| 7601684 |
Diagnosis and treatment of disorders of iron metabolism |
Oct. 13, 2009 |
| 7601683 |
Protein conformational isomers, methods of making, methods for using, compositions comprising and products made therewith |
Oct. 13, 2009 |
| 7601540 |
Gamma secretase notch biomarkers |
Oct. 13, 2009 |
| 7601516 |
Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility |
Oct. 13, 2009 |
| 7601341 |
Vascular endothelial growth factor fusion constructs used to inhibit osteoclastogenesis |
Oct. 13, 2009 |
| 7598219 |
Implants comprising an osteoinductive factor and a contrast agent compatible therewith |
Oct. 6, 2009 |
| 7595296 |
Mutant polypeptides of fibroblast growth factor 1 |
Sep. 29, 2009 |
| 7595294 |
Vasoactive intestinal polypeptide pharmaceuticals |
Sep. 29, 2009 |
| 7595293 |
Stable pharmaceutical compositions |
Sep. 29, 2009 |
| 7595292 |
Conjugated biological molecules and their preparation |
Sep. 29, 2009 |
| 7595062 |
Joint resurfacing orthopaedic implant and associated method |
Sep. 29, 2009 |
| 7595056 |
Methods of rejuvenating Leydig cells and enhancing testosterone production in a male subject |
Sep. 29, 2009 |
| 7595052 |
Composition and method for the prevention and/or the treatment of allergy |
Sep. 29, 2009 |
| 7595044 |
Artery-and vein-specific proteins and uses therefor |
Sep. 29, 2009 |
| 7595038 |
Methods of treatment using antibodies to follistatin-3 |
Sep. 29, 2009 |
| 7592319 |
Uses of DNA-PK |
Sep. 22, 2009 |
| 7592314 |
Use of VEGF and homologues to treat neuron disorders |
Sep. 22, 2009 |
| 7592309 |
Method of using a peptide having analgesic and antitumor activity from scorpion |
Sep. 22, 2009 |
| 7592307 |
Releasable linkage and compositions containing same |
Sep. 22, 2009 |
| 7592306 |
Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
Sep. 22, 2009 |
| 7592305 |
Use of ghrelin for treating malnutrition in gastrectomized individuals |
Sep. 22, 2009 |
| 7592304 |
Metal-binding compounds and uses therefor |
Sep. 22, 2009 |
| 7592188 |
Live cell biosensors |
Sep. 22, 2009 |
| 7592017 |
Resorbable thin membranes |
Sep. 22, 2009 |
| 7592009 |
Polypeptide ligands for targeting cartilage and methods of use thereof |
Sep. 22, 2009 |
| 7591999 |
Powdery preparation for nasal administration |
Sep. 22, 2009 |
| 7589060 |
Therapeutic agent for hair-related problems and method for screening for the same |
Sep. 15, 2009 |
| 7589059 |
Delivery of molecules and complexes to mammalian cells in vivo |
Sep. 15, 2009 |
| 7589058 |
Ghrelin analogs |
Sep. 15, 2009 |
| 7588912 |
Compositions and methods for preventing and treating anthrax diseases |
Sep. 15, 2009 |
| 7588763 |
Methods for the prevention against or treatment of diabetes with ETXB and/or insulin |
Sep. 15, 2009 |
| 7585847 |
Immunostimulatory nucleic acids for the treatment of asthma and allergy |
Sep. 8, 2009 |
| 7585838 |
Methods of treating fibromyalgia caused by small intestinal bacterial overgrowth |
Sep. 8, 2009 |
| 7585837 |
Reversible pegylated drugs |
Sep. 8, 2009 |
| 7585836 |
Bi-lateral local renal delivery for treating congestive heart failure and for BNP therapy |
Sep. 8, 2009 |
| 7585835 |
GASP1: a follistatin domain containing protein |
Sep. 8, 2009 |
| 7585834 |
Transporters comprising spaced arginine moieties |
Sep. 8, 2009 |
| 7585509 |
Erb-2 receptor targeting peptide |
Sep. 8, 2009 |
|
|
|
